Big Pharma Fined $489 Million for Bribing Doctors

(Reuters) – China fined GlaxoSmithKline Plc (GSK.L) a record 3 billion yuan ($490 million) on Friday for paying bribes to doctors to use its drugs, underlining the risks of doing business there while also ending a damaging chapter for the British drugmaker.A court in the southern city of Changsha also sentenced Mark Reilly, the former head of GSK in China, and other GSK executives to between two and four years in jail, according to state news agency Xinhua.However, Briton Reilly, shown on state television wearing a suit and looking tired during the trial, will be deported and will not face jail time in China, a source with direct knowledge of the case said.“Reilly will be deported so he won’t be in detention in China,” said the source, who declined to be named because of the sensitivity of the case.The verdict, handed out behind closed doors in a single-day trial according to Xinhua, highlights how Chinese regulators are increasingly cracking down on bad behavior.

via Big Pharma Fined $489 Million for Bribing Doctors.

About arjsto

This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s